As of Aug 23
| +0.07 / +0.87%|
The 8 analysts offering 12-month price forecasts for Epizyme Inc have a median target of 23.50, with a high estimate of 39.00 and a low estimate of 17.00. The median estimate represents a +189.05% increase from the last price of 8.13.
The current consensus among 9 polled investment analysts is to Buy stock in Epizyme Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.